SARAJEVO (Bosnia and Herzegovina), May 6 (SeeNews) – The pending sale of the state-owned minority stake in drug firm Bosnalijek would not only raise the price of one of Bosnia’s most liquid stocks but will also animate the entire market, brokers said.